USP General Chapter <800> — Hazardous Drugs Handling in Healthcare Settings

Citation

United States Pharmacopeia, General Chapter <800> Hazardous Drugs — Handling in Healthcare Settings. Official December 1, 2019. Made compendially applicable (enforceable through USP-NF integration) November 1, 2023, concurrent with the revised USP <797> effective date. Enforcement occurs through state pharmacy board adoption, OSHA hazard communication enforcement, and accrediting body standards.

What It Says (Operative Provisions Relevant to Pest Management)

USP <800> governs the handling of hazardous drugs throughout healthcare facilities — from receiving and storage through compounding, dispensing, administration, waste handling, and environmental decontamination. The chapter does not contain pest-specific language, but its environmental requirements have direct implications for pest management in hazardous drug handling areas.

Containment requirements:

Hazardous drugs must be received, stored, compounded, and disposed of in designated areas with documented containment controls. Negative pressure ventilation, dedicated equipment, and restricted access are required for compounding areas. Pest management activities in these areas must not compromise containment.

Surface and facility design:

Like USP <797>, USP <800> requires hazardous drug handling areas to have smooth, impervious, non-shedding surfaces that can be effectively decontaminated. Floor-to-ceiling junctions, wall penetrations, and equipment seals must be designed to prevent contamination accumulation. These same design features serve pest exclusion.

Environmental wipe sampling:

USP <800> requires periodic environmental wipe sampling for hazardous drug surface contamination. Wipe sampling locations and frequencies are specified in the facility’s hazardous drug program. Pest activity in hazardous drug handling areas — particularly insect activity that could mobilize hazardous drug residues — represents a containment failure requiring investigation.

Cleaning and decontamination protocols:

Hazardous drug handling areas require specific cleaning and decontamination procedures using designated agents. Pest management products applied in these areas must be compatible with hazardous drug decontamination chemistry and must not interfere with environmental wipe sampling.

Spill response protocols:

USP <800> requires written spill response protocols for hazardous drug events. Pest activity that disturbs hazardous drug containers, packaging, or residues triggers spill response — pest management is therefore operationally intertwined with hazardous drug spill management.

What It Means in Plain Language

USP <800> is the federal standard of care for hazardous drug handling — including chemotherapy agents, immunosuppressants, antiviral drugs, hormones, and other agents on the NIOSH Hazardous Drug List. Hazardous drugs are present in virtually every acute-care hospital pharmacy and in many ambulatory care, long-term care, and pediatric facility settings.

The practical implication for pest management programs serving hazardous drug handling areas:

1. Pesticide application in hazardous drug handling areas requires hazardous drug program coordination. Any chemical pest control intervention must be evaluated for compatibility with hazardous drug containment, decontamination chemistry, and environmental wipe sampling protocols. Standard pest control products may interfere with hazardous drug surface testing — creating false-negative or false-positive contamination results.
2. Pest activity in hazardous drug handling areas is a containment event. Insects, rodents, or pest evidence in hazardous drug receiving, storage, or compounding areas can mobilize hazardous drug residues, breach containment, and contaminate handling personnel. This is a critical safety concern requiring immediate investigation and response.
3. Pest management must coordinate with the Designated Person (or equivalent). Like USP <797>, USP <800> requires designation of a person responsible for the hazardous drug program. Pest management activities affecting hazardous drug areas must be coordinated through this role.
4. Documentation requirements are stringent. Pest management records in hazardous drug areas must include the products used, the rationale for chemical versus non-chemical intervention selection, hazardous drug program coordination evidence, and post-application decontamination verification.

Who It Applies To

USP <800> applies to all healthcare personnel who receive, prepare, transport, administer, or dispose of hazardous drugs in any healthcare setting. This includes:

• Hospital pharmacies (the primary affected population)
• Ambulatory infusion centers
• Oncology clinics
• Long-term care facilities administering hazardous drug therapies
• Pediatric facilities (where hazardous drug exposure protection is especially critical)
• Veterinary facilities handling hazardous drugs (though outside the scope of this human-healthcare reference)

Enforcement occurs through:

• State pharmacy board inspections
• OSHA enforcement under the Hazard Communication Standard and General Duty Clause
• Joint Commission and DNV-GL accreditation standards
• CMS Conditions of Participation through infection prevention and pharmacy services requirements

Documentation Evidence Required

For pest management documentation supporting USP <800> compliance:

• Pest management plan addressing hazardous drug handling areas specifically with documented coordination with the hazardous drug program Designated Person
• Product selection documentation demonstrating evaluation of pest control product compatibility with hazardous drug decontamination protocols
• Service records for hazardous drug areas with explicit documentation of pre-service hazardous drug program coordination and post-service decontamination verification
• Wipe sampling coordination demonstrating that pest management activities are timed and conducted in a manner that does not compromise environmental wipe sampling integrity
• Spill response coordination documenting how pest events trigger hazardous drug spill response when applicable

How Surveyors Evaluate It

State pharmacy board inspectors evaluate USP <800> compliance directly. Joint Commission and DNV-GL surveyors evaluate hospital hazardous drug programs under both their accreditation standards and USP <800> as the underlying standard of care. OSHA evaluates hazardous drug handling under the Hazard Communication Standard and the General Duty Clause where worker exposure is at issue.

Common pest-related findings during USP <800> evaluation:

• Evidence of pest activity in hazardous drug receiving, storage, or compounding areas
• Inadequate physical exclusion at hazardous drug area entry points
• Pest management activities conducted without hazardous drug program coordination
• Pest control product selection that compromises hazardous drug decontamination protocols
• Pest management documentation that does not distinguish hazardous drug area service from general facility service

Confidence Notes

MEDIUM confidence. USP General Chapter <800> verbatim text is paywalled in the USP-NF compendia. Operational requirements summarized on this page are derived from publicly available USP FAQ documents, NIOSH Hazardous Drug List references, state pharmacy board adoption materials, and accrediting body summaries. Effective date (December 1, 2019) and compendial applicability date (November 1, 2023) verified from USP public metadata. Verbatim quotation of <800> requirements requires institutional USP-NF access.

Related Killed Claims

No fabricated claims about USP <800> identified in foundation research.

Related Authorities

• USP General Chapter <797> — Sterile Compounding — companion chapter for sterile pharmaceutical compounding with overlapping environmental requirements
• OSHA Hazard Communication Standard — applicable to both pesticides and hazardous drugs, with intersecting documentation requirements
• CDC HICPAC Section E.V. — healthcare facility pest management standards referenced as standard of care